Cargando…
Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466234/ https://www.ncbi.nlm.nih.gov/pubmed/30875996 http://dx.doi.org/10.3390/vaccines7010032 |
| _version_ | 1783411061719826432 |
|---|---|
| author | Paynter, Janine Goodyear-Smith, Felicity Morgan, Jane Saxton, Peter Black, Steven Petousis-Harris, Helen |
| author_facet | Paynter, Janine Goodyear-Smith, Felicity Morgan, Jane Saxton, Peter Black, Steven Petousis-Harris, Helen |
| author_sort | Paynter, Janine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6466234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64662342019-04-18 Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” Paynter, Janine Goodyear-Smith, Felicity Morgan, Jane Saxton, Peter Black, Steven Petousis-Harris, Helen Vaccines (Basel) Reply MDPI 2019-03-15 /pmc/articles/PMC6466234/ /pubmed/30875996 http://dx.doi.org/10.3390/vaccines7010032 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Reply Paynter, Janine Goodyear-Smith, Felicity Morgan, Jane Saxton, Peter Black, Steven Petousis-Harris, Helen Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title | Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title_full | Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title_fullStr | Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title_full_unstemmed | Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title_short | Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| title_sort | reply to “comment on effectiveness of a group b outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in new zealand: a retrospective cohort study, vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005” |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466234/ https://www.ncbi.nlm.nih.gov/pubmed/30875996 http://dx.doi.org/10.3390/vaccines7010032 |
| work_keys_str_mv | AT paynterjanine replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 AT goodyearsmithfelicity replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 AT morganjane replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 AT saxtonpeter replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 AT blacksteven replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 AT petousisharrishelen replytocommentoneffectivenessofagroupboutermembranevesiclemeningococcalvaccineinpreventinghospitalizationfromgonorrheainnewzealandaretrospectivecohortstudyvaccines201915doi103390vaccines7010005 |